561 related articles for article (PubMed ID: 29540185)
21. LINC01354 interacting with hnRNP-D contributes to the proliferation and metastasis in colorectal cancer through activating Wnt/β-catenin signaling pathway.
Li J; He M; Xu W; Huang S
J Exp Clin Cancer Res; 2019 Apr; 38(1):161. PubMed ID: 30987669
[TBL] [Abstract][Full Text] [Related]
22. LncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of HCC by regulating UPF1 and Wnt-signaling pathway.
Li Y; Hu J; Guo D; Ma W; Zhang X; Zhang Z; Lu G; He S
Cancer Gene Ther; 2022 Oct; 29(10):1373-1383. PubMed ID: 35338348
[TBL] [Abstract][Full Text] [Related]
23. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
24. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract][Full Text] [Related]
25. Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT.
Fan X; Song J; Zhao Z; Chen M; Tu J; Lu C; Wu F; Zhang D; Weng Q; Zheng L; Xu M; Ji J
Cancer Lett; 2019 Sep; 460():119-127. PubMed ID: 31207322
[TBL] [Abstract][Full Text] [Related]
26. Targeting the Epigenetic Non-Coding RNA MALAT1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma.
Chang HL; Bamodu OA; Ong JR; Lee WH; Yeh CT; Tsai JT
Cells; 2020 Apr; 9(4):. PubMed ID: 32326045
[TBL] [Abstract][Full Text] [Related]
27. LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway.
Wang F; Zhu W; Yang R; Xie W; Wang D
Mol Cell Biochem; 2019 Jun; 456(1-2):73-83. PubMed ID: 30635820
[TBL] [Abstract][Full Text] [Related]
28. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
Pandit H; Li Y; Li X; Zhang W; Li S; Martin RCG
BMC Cancer; 2018 Aug; 18(1):783. PubMed ID: 30075764
[TBL] [Abstract][Full Text] [Related]
29. Wnt/β-catenin activation and macrophage induction during liver cancer development following steatosis.
Debebe A; Medina V; Chen CY; Mahajan IM; Jia C; Fu D; He L; Zeng N; Stiles BW; Chen CL; Wang M; Aggarwal KR; Peng Z; Huang J; Chen J; Li M; Dong T; Atkins S; Borok Z; Yuan W; Machida K; Ju C; Kahn M; Johnson D; Stiles BL
Oncogene; 2017 Oct; 36(43):6020-6029. PubMed ID: 28671671
[TBL] [Abstract][Full Text] [Related]
30. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
[TBL] [Abstract][Full Text] [Related]
32. Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.
Cheng Y; Cheung AK; Ko JM; Phoon YP; Chiu PM; Lo PH; Waterman ML; Lung ML
BMC Cell Biol; 2013 Sep; 14():44. PubMed ID: 24073846
[TBL] [Abstract][Full Text] [Related]
33. Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/β-catenin signaling in hepatocellular carcinoma.
Lin X; Chen J; Li X; Chen D; Luo K; Deng Y; Yang D; Huang Z; Tao C
Arch Toxicol; 2023 Jun; 97(6):1627-1647. PubMed ID: 37120773
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
Liu M; Bamodu OA; Kuo KT; Lee WH; Lin YK; Wu ATH; M H; Tzeng YM; Yeh CT; Tsai JT
Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038
[TBL] [Abstract][Full Text] [Related]
35. The Alteration of CTNNBIP1 in Lung Cancer.
Chang JM; Tsai AC; Huang WR; Tseng RC
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766223
[TBL] [Abstract][Full Text] [Related]
36. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
37. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
[TBL] [Abstract][Full Text] [Related]
38. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway.
Bi W; Huang J; Nie C; Liu B; He G; Han J; Pang R; Ding Z; Xu J; Zhang J
J Exp Clin Cancer Res; 2018 Nov; 37(1):275. PubMed ID: 30424816
[TBL] [Abstract][Full Text] [Related]
39. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling.
Pan J; Fang S; Tian H; Zhou C; Zhao X; Tian H; He J; Shen W; Meng X; Jin X; Gong Z
Mol Cancer; 2020 Jan; 19(1):9. PubMed ID: 31941509
[TBL] [Abstract][Full Text] [Related]
40. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.
Kim JY; Lee HY; Park KK; Choi YK; Nam JS; Hong IS
Oncotarget; 2016 Apr; 7(15):20395-409. PubMed ID: 26967248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]